|
DE19812481C2
(de)
*
|
1998-03-21 |
2002-08-22 |
Johann Rath |
Vorrichtung zur Dämpfung von Schallemissionen an Gleisanlagen
|
|
DE29905550U1
(de)
*
|
1999-03-26 |
2000-08-24 |
DVG Deutsche Verpackungsmittel GmbH, 90552 Röthenbach |
Absorptionsbelag zur Reduzierung der Schallabstrahlung für Gleiskörper
|
|
US7166719B2
(en)
|
2002-06-27 |
2007-01-23 |
Health Research, Inc. |
Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy
|
|
US7897140B2
(en)
|
1999-12-23 |
2011-03-01 |
Health Research, Inc. |
Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
|
|
US6481637B1
(en)
*
|
2000-11-20 |
2002-11-19 |
Mcqueen Philip Jeffrey |
Rail pad and method for strain attentuation
|
|
DE10111919A1
(de)
*
|
2001-03-13 |
2002-09-19 |
Boegl Max Bauunternehmung Gmbh |
Fahrwegträger
|
|
HU224236B1
(hu)
*
|
2001-12-14 |
2005-06-28 |
Attila Szebeni |
Vasúti acélhidaknál alkalmazható, egymáshoz csatlakoztatott elemekbõl álló, zaj- és rezgéscsökkentett mûanyag járólemezrendszer
|
|
US8829198B2
(en)
|
2007-10-31 |
2014-09-09 |
Proteotech Inc |
Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
|
|
AU2003249742A1
(en)
|
2002-07-02 |
2004-01-23 |
Health Research, Inc. |
Efficient synthesis of pyropheophorbide a and its derivatives
|
|
AT6414U1
(de)
*
|
2002-07-17 |
2003-10-27 |
Gmundner Fertigteile Gmbh |
Gleisabdeckung
|
|
GB2399123B
(en)
*
|
2003-03-05 |
2006-03-01 |
Corus Uk Ltd |
Rail damper
|
|
US20040248877A1
(en)
*
|
2003-04-30 |
2004-12-09 |
Sandeep Gupta |
Polycyclic diazodioxide-based Bcl-2 protein antagonists and use thereof
|
|
US20040242886A1
(en)
*
|
2003-04-30 |
2004-12-02 |
Sandeep Gupta |
Monocyclic diazodioxide based Bcl-2 protein antagonists related applications
|
|
BRPI0410348A
(pt)
*
|
2003-05-14 |
2006-05-30 |
Torreypines Therapeutics Inc |
compostos e usos dos mesmos na modulação de amilóide-beta
|
|
US20090227647A1
(en)
*
|
2008-03-05 |
2009-09-10 |
Thomas Lake |
Compounds, Compositions and Methods for the Treatment of Islet Amyloid Polypeptide (IAPP) Accumulation in Diabetes
|
|
US8916598B2
(en)
|
2003-05-30 |
2014-12-23 |
Proteotech Inc |
Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies
|
|
US20100331380A1
(en)
*
|
2009-06-29 |
2010-12-30 |
Esposito Luke A |
Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies
|
|
WO2005090370A1
(en)
|
2004-02-05 |
2005-09-29 |
The Regents Of The University Of California |
Pharmacologically active agents containing esterified phosphonates and methods for use thereof
|
|
US7546900B2
(en)
*
|
2004-02-12 |
2009-06-16 |
Evonik Cyro Llc |
Panel assembly for traffic noise barrier wall
|
|
US8616331B2
(en)
|
2004-02-12 |
2013-12-31 |
Eric C. Humphries |
Panel assembly for traffic noise barrier wall
|
|
US20100126797A1
(en)
*
|
2004-02-12 |
2010-05-27 |
Humphries Eric C |
Panel Assembly For Traffic Noise Barrier Wall
|
|
TWI347390B
(en)
*
|
2004-03-05 |
2011-08-21 |
Gmundner Fertigteile Gmbh |
Noise-reducing track cover
|
|
US20050261365A1
(en)
|
2004-05-20 |
2005-11-24 |
The Scripps Research Institute |
Transthyretin stabilization
|
|
EP1802303B1
(en)
|
2004-09-17 |
2011-11-02 |
Whitehead Institute For Biomedical Research |
Compounds, compositions and methods of inhibiting a-synuclein toxicity
|
|
US20060067889A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Light Sciences Corporation |
Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents
|
|
US20070131480A1
(en)
*
|
2004-12-06 |
2007-06-14 |
Corbin Maxwell H Jr |
Sound arresting barrier
|
|
US7464791B2
(en)
*
|
2005-01-27 |
2008-12-16 |
Pretty Products, Llc |
Acoustic mats and methods for making the same
|
|
US20060230699A1
(en)
*
|
2005-03-22 |
2006-10-19 |
Keene James R |
Sound control flooring systems and methods therefor
|
|
CN101189249B
(zh)
|
2005-04-01 |
2013-04-17 |
加利福尼亚大学董事会 |
膦酰基-戊-2-烯-1-基核苷和类似物
|
|
US20090156545A1
(en)
*
|
2005-04-01 |
2009-06-18 |
Hostetler Karl Y |
Substituted Phosphate Esters of Nucleoside Phosphonates
|
|
WO2008051197A2
(en)
*
|
2005-09-20 |
2008-05-02 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
|
US8138361B2
(en)
*
|
2005-12-28 |
2012-03-20 |
The Trustees Of The University Of Pennsylvania |
C-10 carbamates of taxanes
|
|
US8063221B2
(en)
*
|
2006-03-13 |
2011-11-22 |
Kyorin Pharmaceutical Co., Ltd. |
Aminoquinolones as GSK-3 inhibitors
|
|
WO2007126841A2
(en)
*
|
2006-03-29 |
2007-11-08 |
Foldrx Pharmaceuticals, Inc. |
Inhibition of alpha-synuclein toxicity
|
|
WO2007143781A1
(en)
*
|
2006-06-13 |
2007-12-21 |
Newstyle Nominees Pty Ltd |
Rail track crossing
|
|
KR101374983B1
(ko)
|
2006-08-28 |
2014-03-17 |
라 졸라 인스티튜트 포 앨러지 앤드 이뮤놀로지 |
길항성 인간 ｌｉｇｈｔ-특이적 인간 모노클로날 항체를 포함하는 제약 조성물
|
|
DK2066662T3
(da)
|
2006-09-21 |
2013-01-07 |
Kyorin Seiyaku Kk |
Serinhydrolaseinhibitorer
|
|
DE602007013440D1
(de)
|
2006-10-19 |
2011-05-05 |
Auspex Pharmaceuticals Inc |
Substituierte indole
|
|
JP5013590B2
(ja)
*
|
2006-11-14 |
2012-08-29 |
エンデバーハウス株式会社 |
伸縮性に優れた線路用吸音材
|
|
AU2007333667A1
(en)
|
2006-12-19 |
2008-06-26 |
Auspex Pharmaceuticals, Inc. |
Preperation and utility of CCR5 inhibitors
|
|
AU2007338689A1
(en)
*
|
2006-12-22 |
2008-07-03 |
Encysive Pharmaceuticals, Inc. |
Modulators of C3a receptor and methods of use thereof
|
|
WO2008106167A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Conatus Pharmaceuticals, Inc. |
Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases
|
|
DK2144604T3
(da)
|
2007-02-28 |
2011-10-17 |
Conatus Pharmaceuticals Inc |
Fremgangsmåder til behandling af kronisk viral hepatitis C under anvendelse af RO 113-0830
|
|
EP3269706A1
(en)
|
2007-03-15 |
2018-01-17 |
Auspex Pharmaceuticals, Inc. |
Deuterated o-desmethylvenlafaxine with serotoninergic and/or norepinephrinergic activity
|
|
US7892776B2
(en)
|
2007-05-04 |
2011-02-22 |
The Regents Of The University Of California |
Screening assay to identify modulators of protein kinase A
|
|
JP2010533205A
(ja)
*
|
2007-07-12 |
2010-10-21 |
トラガラ ファーマシューティカルズ，インク． |
癌、腫瘍、および腫瘍関連障害を治療するための方法および組成物
|
|
CA2699151A1
(en)
*
|
2007-09-11 |
2009-03-19 |
Activx Biosciences, Inc. |
Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors
|
|
JP5373799B2
(ja)
|
2007-09-12 |
2013-12-18 |
杏林製薬株式会社 |
Ｇｓｋ−３阻害剤としてのスピロ環式アミノキノロン
|
|
US20090264421A1
(en)
*
|
2007-10-05 |
2009-10-22 |
Bible Keith C |
Methods and Compositions for Treating Cancer
|
|
CN101849068B
(zh)
*
|
2007-11-07 |
2013-01-02 |
何伟麟 |
可调谐震动吸收装置
|
|
CN101917845A
(zh)
|
2007-11-21 |
2010-12-15 |
法马克西斯制药公司 |
Ssao/vap-1的卤代烯丙胺抑制剂及其用途
|
|
NZ587907A
(en)
|
2008-03-17 |
2012-09-28 |
Ambit Biosciences Corp |
Quinazoline derivatives as RAF kinase modulators and methods of use thereof
|
|
US20120034156A1
(en)
*
|
2010-08-03 |
2012-02-09 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Artificial cells
|
|
CN101658533A
(zh)
*
|
2008-08-29 |
2010-03-03 |
首都医科大学宣武医院 |
抗肿瘤药物的干细胞递送
|
|
US8048204B2
(en)
|
2008-09-23 |
2011-11-01 |
Rwdi Air Inc. |
Wall assembly
|
|
WO2010088450A2
(en)
|
2009-01-30 |
2010-08-05 |
Celladon Corporation |
Methods for treating diseases associated with the modulation of serca
|
|
US8568793B2
(en)
|
2009-02-11 |
2013-10-29 |
Hope Medical Enterprises, Inc. |
Sodium nitrite-containing pharmaceutical compositions
|
|
AU2010217929B2
(en)
|
2009-02-27 |
2016-07-14 |
Ambit Biosciences Corporation |
JAK kinase modulating quinazoline derivatives and methods of use thereof
|
|
JP5690286B2
(ja)
|
2009-03-04 |
2015-03-25 |
イデニク プハルマセウティカルス，インコーポレイテッド |
ホスホチオフェン及びホスホチアゾールｈｃｖポリメラーゼ阻害剤
|
|
MX2011009414A
(es)
*
|
2009-03-11 |
2011-10-19 |
Kyorin Seiyaku Kk |
7-cicloalquiloaminoquinolonas como inhibidores de gsk-3.
|
|
US8146310B2
(en)
*
|
2009-03-11 |
2012-04-03 |
Keene Building Products Co., Inc. |
Noise control flooring system
|
|
WO2010105016A1
(en)
|
2009-03-11 |
2010-09-16 |
Ambit Biosciences Corp. |
Combination of an indazolylaminopyrrolotriazine and taxane for cancer treatment
|
|
MX2011010105A
(es)
|
2009-03-27 |
2012-01-12 |
Pathway Therapeutics Inc |
Sulfonamidas de pirimidinilo y 1,3,5-triazinilo benzimidazol y su uso en terapia de cancer.
|
|
WO2010110686A1
(en)
|
2009-03-27 |
2010-09-30 |
Pathway Therapeutics Limited |
Pyrimidinyl and 1,3,5 triazinyl benzimidazoles and their use in cancer therapy
|
|
PE20120811A1
(es)
|
2009-04-22 |
2012-07-08 |
Axikin Pharmaceuticals Inc |
Antagonistas ccr3 arilsulfonamida
|
|
AR078120A1
(es)
|
2009-04-22 |
2011-10-19 |
Axikin Pharmaceuticals Inc |
Antagonistas de ccr3 de arilsulfonamida 2,5-disustituida y composiciones farmaceuticas
|
|
CA2758968C
(en)
|
2009-04-22 |
2018-05-29 |
Axikin Pharmaceuticals, Inc. |
2,5-disubstituted arylsulfonamide ccr3 antagonists
|
|
WO2011003870A2
(en)
|
2009-07-06 |
2011-01-13 |
Creabilis S.A. |
Mini-pegylated corticosteroids, compositions including same, and methods of making and using same
|
|
AR080945A1
(es)
|
2009-07-07 |
2012-05-23 |
Pathway Therapeutics Inc |
Pirimidinil y 1,3,5-triazinil benzimidazoles y su uso en la terapia contra el cancer
|
|
WO2011005841A1
(en)
|
2009-07-08 |
2011-01-13 |
Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals |
Sodium thiosulfate-containing pharmaceutical compositions
|
|
US8404728B2
(en)
|
2009-07-30 |
2013-03-26 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
|
CA2769652A1
(en)
|
2009-08-05 |
2011-02-10 |
Idenix Pharmaceuticals, Inc. |
Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv
|
|
KR20120059558A
(ko)
|
2009-08-19 |
2012-06-08 |
암비트 바이오사이언시즈 코포레이션 |
바이아릴 화합물 및 이의 사용 방법
|
|
NL2003697C2
(nl)
|
2009-10-22 |
2011-04-26 |
Univ Twente |
Weg met geluid-diffractoren.
|
|
US8470817B2
(en)
*
|
2009-10-26 |
2013-06-25 |
Sunesis Pharmaceuticals, Inc. |
Compounds and methods for treatment of cancer
|
|
WO2011056764A1
(en)
|
2009-11-05 |
2011-05-12 |
Ambit Biosciences Corp. |
Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
|
|
EP2499282B1
(en)
|
2009-11-09 |
2015-04-22 |
NeuroGenetic Pharmaceuticals, Inc. |
Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor
|
|
US8528286B2
(en)
*
|
2009-11-10 |
2013-09-10 |
Keene Building Products Co., Inc. |
Sound control mat
|
|
WO2011069002A1
(en)
|
2009-12-02 |
2011-06-09 |
Alquest Therapeutics, Inc. |
Organoselenium compounds and uses thereof
|
|
NZ600608A
(en)
|
2009-12-18 |
2015-01-30 |
Idenix Pharmaceuticals Inc |
5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
|
|
WO2011079313A1
(en)
*
|
2009-12-23 |
2011-06-30 |
Map Pharmaceuticals, Inc. |
Novel ergoline analogs
|
|
WO2011094890A1
(en)
|
2010-02-02 |
2011-08-11 |
Argusina Inc. |
Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
|
|
HUE025699T2
(en)
|
2010-03-02 |
2016-04-28 |
Axikin Pharmaceuticals Inc |
Isotopically enriched arylsulfonamide derivatives as CCR3 antagonists
|
|
WO2011112689A2
(en)
|
2010-03-11 |
2011-09-15 |
Ambit Biosciences Corp. |
Saltz of an indazolylpyrrolotriazine
|
|
US8741894B2
(en)
|
2010-03-17 |
2014-06-03 |
Axikin Pharmaceuticals, Inc. |
Arylsulfonamide CCR3 antagonists
|
|
WO2011150198A1
(en)
|
2010-05-27 |
2011-12-01 |
Ambit Biosciences Corporation |
Azolyl urea compounds and methods of use thereof
|
|
WO2011150201A2
(en)
|
2010-05-27 |
2011-12-01 |
Ambit Biosciences Corporation |
Azolyl amide compounds and methods of use thereof
|
|
CN103038216A
(zh)
|
2010-06-01 |
2013-04-10 |
拜欧赛里克斯公司 |
羟基吡啶酮衍生物、其药物组合物及其用于治疗增生性疾病的治疗用途
|
|
WO2011153199A1
(en)
|
2010-06-01 |
2011-12-08 |
Biotheryx, Inc. |
Methods of treating hematologic malignancies using 6-cyclohexyl-1-hydroxy-4-methyl-2(1h)-pyridone
|
|
WO2011156321A1
(en)
|
2010-06-07 |
2011-12-15 |
Novomedix, Llc |
Furanyl compounds and the use thereof
|
|
US20130178522A1
(en)
|
2010-07-19 |
2013-07-11 |
James M. Jamison |
Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease
|
|
US20140200270A1
(en)
|
2013-01-11 |
2014-07-17 |
Summa Health System |
Vitamins c and k for treating polycystic diseases
|
|
US8703943B2
(en)
|
2010-09-01 |
2014-04-22 |
Ambit Biosciences Corporation |
Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
|
|
US8633207B2
(en)
|
2010-09-01 |
2014-01-21 |
Ambit Biosciences Corporation |
Quinazoline compounds and methods of use thereof
|
|
WO2012030944A2
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
Quinoline and isoquinoline compounds and methods of use thereof
|
|
WO2012030912A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
7-cyclylquinazoline derivatives and methods of use thereof
|
|
US20120053176A1
(en)
|
2010-09-01 |
2012-03-01 |
Ambit Biosciences Corp. |
Adenosine a3 receptor modulating compounds and methods of use thereof
|
|
EP2611809A1
(en)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
Azolopyridine and azolopyrimidine compounds and methods of use thereof
|
|
ES2619850T3
(es)
|
2010-09-01 |
2017-06-27 |
Ambit Biosciences Corporation |
Sales de hidrobromuro de una pirazolilaminoquinazolina
|
|
EP2611812A1
(en)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
Thienopyridine and thienopyrimidine compounds and methods of use thereof
|
|
WO2012030910A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
2-cycloquinazoline derivatives and methods of use thereof
|
|
WO2012030914A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Boisciences Corporation |
4-azolylaminoquinazoline derivatives and methods of use thereof
|
|
WO2012044641A1
(en)
|
2010-09-29 |
2012-04-05 |
Pathway Therapeutics Inc. |
1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
|
|
WO2012051090A1
(en)
|
2010-10-11 |
2012-04-19 |
Axikin Pharmaceuticals, Inc. |
Salts of arylsulfonamide ccr3 antagonists
|
|
US20120125711A1
(en)
*
|
2010-11-24 |
2012-05-24 |
Stahr Richard E |
Sound absorbing panel and system
|
|
AU2011338530B2
(en)
|
2010-12-06 |
2017-06-15 |
Follica, Inc. |
Methods for treating baldness and promoting hair growth
|
|
WO2012080050A1
(en)
|
2010-12-14 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Solid forms of a phenoxybenzenesulfonyl compound
|
|
US20120189633A1
(en)
|
2011-01-26 |
2012-07-26 |
Kolltan Pharmaceuticals, Inc. |
Anti-kit antibodies and uses thereof
|
|
EP2670396A1
(en)
|
2011-01-31 |
2013-12-11 |
Celgene Corporation |
Pharmaceutical compositions of cytidine analogs and methods of use thereof
|
|
TW201309690A
(zh)
|
2011-02-10 |
2013-03-01 |
Idenix Pharmaceuticals Inc |
巨環絲胺酸蛋白酶抑制劑，其醫藥組合物及其於治療ｈｃｖ感染之用途
|
|
WO2012135166A1
(en)
|
2011-03-28 |
2012-10-04 |
Pathway Therapeutics Inc. |
(fused ring arylamino and heterocyclylamino) pyrimidynyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
|
|
AU2012236722A1
(en)
|
2011-03-28 |
2013-10-17 |
Mei Pharma, Inc. |
(alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
|
|
CA2831582C
(en)
|
2011-03-28 |
2019-01-08 |
Mei Pharma, Inc. |
(alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
|
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
|
EP2723735A4
(en)
|
2011-06-23 |
2015-02-18 |
Map Pharmaceuticals Inc |
NOVEL ANALOGUES OF FLUORO-ERGOLINE
|
|
WO2013037482A1
(en)
|
2011-09-15 |
2013-03-21 |
Phenex Pharmaceuticals Ag |
Farnesoid x receptor agonists for cancer treatment and prevention
|
|
CN104066730B
(zh)
|
2011-10-14 |
2017-03-08 |
埃姆比特生物科学公司 |
杂环化合物及其作为iii型受体酪氨酸激酶调节剂的用途
|
|
US8592445B2
(en)
|
2011-12-19 |
2013-11-26 |
Map Pharmaceuticals, Inc. |
Iso-ergoline derivatives
|
|
CA2859175A1
(en)
|
2011-12-21 |
2013-06-27 |
Map Pharmaceuticals, Inc. |
Novel neuromodulatory compounds
|
|
US9611253B2
(en)
|
2012-02-29 |
2017-04-04 |
Ambit Biosciences Corporation |
Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith
|
|
MX2014011115A
(es)
|
2012-03-16 |
2015-03-13 |
Axikin Pharmaceuticals Inc |
Inhibidores de 3,5-diaminopirazol cinasa.
|
|
MX377635B
(es)
|
2012-05-02 |
2025-03-11 |
Boehringer Ingelheim Int |
Inhibidores de 3-haloalilamina sustituidos de ssao y uso de los mismos
|
|
US9732038B2
(en)
|
2012-06-14 |
2017-08-15 |
Mayo Foundation For Medical Education And Research |
Pyrazole derivatives as inhibitors of STAT3
|
|
US9012640B2
(en)
|
2012-06-22 |
2015-04-21 |
Map Pharmaceuticals, Inc. |
Cabergoline derivatives
|
|
DK2877493T3
(en)
|
2012-07-25 |
2018-06-14 |
Celldex Therapeutics Inc |
ANTI-KIT ANTIBODIES AND APPLICATIONS THEREOF
|
|
US9074186B2
(en)
|
2012-08-15 |
2015-07-07 |
Boston Medical Center Corporation |
Production of red blood cells and platelets from stem cells
|
|
BR112015004959A2
(pt)
|
2012-09-07 |
2017-07-04 |
Axikin Pharmaceuticals Inc |
composto isotopicamente enriquecido, composição farmacêutica, método para tratar, prevenir ou amenizar um ou mais sintomas de uma doença, distúrbio ou condição mediada por ccr3, relacionada a eosinófilos, relacionada a basófilos, relacionada a mastócitos ou relacionada a mastócitos em um sujeito, método para tratar, prevenir ou amenizar um ou mais sintomas de uma doença inflamatória em um sujeito e método para modular a atividade de ccr3.
|
|
WO2014055647A1
(en)
|
2012-10-03 |
2014-04-10 |
Mei Pharma, Inc. |
(sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases
|
|
EP2916830A2
(en)
|
2012-11-08 |
2015-09-16 |
Summa Health System |
Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing
|
|
EP3447046A1
(en)
|
2012-11-30 |
2019-02-27 |
Novomedix, LLC |
Substituted biaryl sulfonamides and the use thereof
|
|
US9169214B2
(en)
|
2012-12-21 |
2015-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
|
|
WO2014100354A1
(en)
|
2012-12-21 |
2014-06-26 |
Map Pharmaceuticals, Inc. |
Novel methysergide derivatives
|
|
NZ714765A
(en)
|
2013-06-06 |
2021-12-24 |
Pf Medicament |
Anti-c10orf54 antibodies and uses thereof
|
|
DK3019662T3
(da)
*
|
2013-07-07 |
2020-12-07 |
4Silence B V |
Diffraktionsanordning til diffraktion af lyd
|
|
SG11201601341QA
(en)
|
2013-08-30 |
2016-03-30 |
Ambit Biosciences Corp |
Biaryl acetamide compounds and methods of use thereof
|
|
NZ631142A
(en)
|
2013-09-18 |
2016-03-31 |
Axikin Pharmaceuticals Inc |
Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
|
|
WO2015042375A1
(en)
|
2013-09-20 |
2015-03-26 |
Idenix Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
|
US10272117B2
(en)
|
2014-02-24 |
2019-04-30 |
Celgene Corporation |
Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders
|
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
|
US20170066779A1
(en)
|
2014-03-05 |
2017-03-09 |
Idenix Pharmaceuticals Llc |
Solid forms of a flaviviridae virus inhibitor compound and salts thereof
|
|
CN106661027B
(zh)
|
2014-03-20 |
2019-12-24 |
卡佩拉医疗公司 |
苯并咪唑衍生物作为erbb酪氨酸激酶抑制剂用于治疗癌症
|
|
AU2015231202B9
(en)
|
2014-03-20 |
2019-10-24 |
Capella Therapeutics, Inc. |
Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer
|
|
RU2016148364A
(ru)
|
2014-05-12 |
2018-06-13 |
Конатус Фармасьютикалз, Инк. |
Лечение осложнений хронического заболевания печени
|
|
CA2949998A1
(en)
|
2014-05-28 |
2015-12-03 |
Agenus Inc. |
Anti-gitr antibodies and methods of use thereof
|
|
US9527815B2
(en)
|
2014-06-18 |
2016-12-27 |
Biotheryx, Inc. |
Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseases
|
|
US9499514B2
(en)
|
2014-07-11 |
2016-11-22 |
Celgene Corporation |
Antiproliferative compounds and methods of use thereof
|
|
WO2016025129A1
(en)
|
2014-08-14 |
2016-02-18 |
Alhamadsheh Mamoun M |
Conjugation of pharmaceutically active agents with transthyretin ligands through adjustable linkers to increase serum half-life
|
|
SG10201902137PA
(en)
|
2014-09-12 |
2019-04-29 |
Tobira Therapeutics Inc |
Cenicriviroc combination therapy for the treatment of fibrosis
|
|
WO2016065264A1
(en)
|
2014-10-24 |
2016-04-28 |
Biogen Ma Inc. |
Diterpenoid derivatives and methods of use thereof
|
|
CA2972048C
(en)
|
2014-12-22 |
2023-03-07 |
The Rockefeller University |
Anti-mertk agonistic antibodies and uses thereof
|
|
AU2015369690B2
(en)
|
2014-12-23 |
2019-01-17 |
SMA Therapeutics Inc. |
3,5-diaminopyrazole kinase inhibitors
|
|
CN113149982A
(zh)
|
2015-01-20 |
2021-07-23 |
Xoc制药股份有限公司 |
麦角灵化合物及其用途
|
|
HK1247203A1
(zh)
|
2015-01-28 |
2018-09-21 |
上海复旦张江生物医药股份有限公司 |
取代的咪唑并[1，2-α]吡啶-2-基胺化合物及其药物组合物和使用方法
|
|
KR20250005465A
(ko)
|
2015-03-03 |
2025-01-09 |
키맵 리미티드 |
항체, 용도 및 방법
|
|
HRP20201031T1
(hr)
|
2015-05-29 |
2020-10-16 |
Agenus Inc. |
Anti-ctla-4 protutijela i postupci njihove upotrebe
|
|
JP6919099B2
(ja)
|
2015-06-23 |
2021-08-18 |
ニューロクライン バイオサイエンシーズ，インコーポレイテッド |
神経学的疾患または障害を処置するためのｖｍａｔ２阻害剤
|
|
HK1257840A1
(zh)
|
2015-09-01 |
2019-11-01 |
Agenus Inc. |
抗-pd-1抗体及其使用方法
|
|
HRP20240304T1
(hr)
|
2015-10-30 |
2024-05-10 |
Neurocrine Biosciences, Inc. |
Soli valbenazin dihidroklorida i njihovi polimorfi
|
|
WO2017079566A1
(en)
|
2015-11-05 |
2017-05-11 |
Conatus Pharmaceuticals, Inc. |
Caspase inhibitors for use in the treatment of liver cancer
|
|
CN121181546A
(zh)
|
2015-12-02 |
2025-12-23 |
阿斯特来亚治疗有限责任公司 |
哌啶基痛敏肽受体化合物
|
|
US10112924B2
(en)
|
2015-12-02 |
2018-10-30 |
Astraea Therapeutics, Inc. |
Piperdinyl nociceptin receptor compounds
|
|
LT3394057T
(lt)
|
2015-12-23 |
2022-06-27 |
Neurocrine Biosciences, Inc. |
Sintezės būdas, skirtas pagaminti (s)-(2r,3r,11br)-3-izobutil-9,10-dimetoksi-2,3,4,6,7,11b-heksahidro-1h-pirido[2,1-a]izochinolin-2-ilo 2-amino-3-metilbutanoato di(4-metilbenzensulfonatą)
|
|
JP2019500397A
(ja)
|
2015-12-31 |
2019-01-10 |
クオナトウス ファーマシューティカルズ，インコーポレイテッド |
カスパーゼ阻害剤を肝疾患の治療に使用する方法
|
|
TWI782395B
(zh)
|
2016-01-08 |
2022-11-01 |
美商西建公司 |
抗增生化合物，及其醫藥組合物及用途
|
|
MX385964B
(es)
|
2016-01-08 |
2025-03-18 |
Celgene Corp |
Formas sólidas de 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolin-5-il) metil)-2,2-difluoroacetamida y sus composiciones farmacéuticas y usos.
|
|
US10960013B2
(en)
|
2016-03-04 |
2021-03-30 |
East Carolina University |
J-series prostaglandin-ethanolamides as novel therapeutics for skin and/or oral disorders
|
|
JP2019513151A
(ja)
|
2016-03-08 |
2019-05-23 |
ロス ガトス ファーマスーティカルズ， インク．Ｌｏｓ Ｇａｔｏｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
カンプトテシン誘導体及びその使用
|
|
JP2019510085A
(ja)
|
2016-03-08 |
2019-04-11 |
ロス ガトス ファーマスーティカルズ， インク．Ｌｏｓ Ｇａｔｏｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
癌治療のためのナノ粒子ならびに方法および化合物
|
|
EP3442940A1
(en)
|
2016-04-11 |
2019-02-20 |
Clexio Biosciences Ltd. |
Deuterated ketamine derivatives
|
|
US20190160052A1
(en)
|
2016-05-13 |
2019-05-30 |
Institut Pasteur |
Inhibition of beta-2 nicotinic acetylcholine receptors to treat alzheimer's disease pathology
|
|
TWI753910B
(zh)
|
2016-05-16 |
2022-02-01 |
美商拜歐斯瑞克斯公司 |
吡啶硫酮、其醫藥組合物及其治療增生性、炎性、神經退化性或免疫介導疾病之治療用途
|
|
CA3024508A1
(en)
|
2016-05-27 |
2017-11-30 |
Agenus Inc. |
Anti-tim-3 antibodies and methods of use thereof
|
|
DE102016111064A1
(de)
*
|
2016-06-16 |
2017-12-21 |
Vossloh-Werke Gmbh |
Elastisches Element für einen Befestigungspunkt für eine Schiene für Schienenfahrzeuge und Befestigungspunkt
|
|
CN106087611B
(zh)
*
|
2016-06-20 |
2019-07-12 |
勾厚渝 |
轨道交通构件
|
|
JP2019525772A
(ja)
|
2016-07-08 |
2019-09-12 |
スターテン・バイオテクノロジー・ベー・フェー |
抗ａｐｏｃ３抗体およびその使用方法
|
|
WO2018035281A1
(en)
|
2016-08-17 |
2018-02-22 |
North Carolina State University |
Northern-southern route to synthesis of bacteriochlorins
|
|
KR20190058550A
(ko)
|
2016-09-19 |
2019-05-29 |
메이 파마, 아이엔씨. |
병용 요법
|
|
WO2018071500A1
(en)
|
2016-10-11 |
2018-04-19 |
Agenus Inc. |
Anti-lag-3 antibodies and methods of use thereof
|
|
WO2018083248A1
(en)
|
2016-11-03 |
2018-05-11 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses & methods
|
|
US11332521B2
(en)
|
2016-11-07 |
2022-05-17 |
Neuracle Science Co., Ltd. |
Anti-family with sequence similarity 19, member A5 antibodies and method of use thereof
|
|
WO2018089427A1
(en)
|
2016-11-09 |
2018-05-17 |
Novomedix, Llc |
Nitrite salts of 1, 1-dimethylbiguanide, pharmaceutical compositions, and methods of use
|
|
US10106521B2
(en)
|
2016-11-09 |
2018-10-23 |
Phloronol, Inc. |
Eckol derivatives, methods of synthesis and uses thereof
|
|
WO2018102252A1
(en)
|
2016-11-30 |
2018-06-07 |
North Carolina State University |
Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds
|
|
US10799503B2
(en)
|
2016-12-01 |
2020-10-13 |
Ignyta, Inc. |
Methods for the treatment of cancer
|
|
EP4400171A3
(en)
|
2016-12-02 |
2024-09-11 |
Neurocrine Biosciences, Inc. |
Use of valbenazine for treating schizophrenia or schizoaffective disorder
|
|
AU2017373945B2
(en)
|
2016-12-07 |
2025-01-23 |
Agenus Inc. |
Antibodies and methods of use thereof
|
|
US11013802B2
(en)
|
2016-12-07 |
2021-05-25 |
Agenus Inc. |
Anti-CTLA-4 antibodies and methods of use thereof
|
|
KR20190108146A
(ko)
|
2017-01-27 |
2019-09-23 |
뉴로크린 바이오사이언시즈 인코퍼레이티드 |
특정 vmat2 억제제의 투여 방법
|
|
AU2018220515B2
(en)
|
2017-02-17 |
2022-06-30 |
DayLife LLC |
Universal antivenom
|
|
CN116730921A
(zh)
|
2017-02-17 |
2023-09-12 |
文涵治疗有限公司 |
Ag-10的制备方法、其中间体及其盐
|
|
WO2018164996A1
(en)
|
2017-03-06 |
2018-09-13 |
Neurocrine Biosciences, Inc. |
Dosing regimen for valbenazine
|
|
MX2019011624A
(es)
|
2017-03-27 |
2019-12-05 |
Celgene Corp |
Metodos y composiciones para la reduccion de la inmunogenicidad.
|
|
JP7297672B2
(ja)
|
2017-04-13 |
2023-06-26 |
アジェナス インコーポレイテッド |
抗ｃｄ１３７抗体およびその使用方法
|
|
MA50958A
(fr)
|
2017-04-21 |
2020-10-14 |
Staten Biotechnology B V |
Anticorps anti-apoc3 et leurs méthodes d'utilisation
|
|
US20200179352A1
(en)
|
2017-04-26 |
2020-06-11 |
Neurocrine Biosciences, Inc. |
Use of valbenazine for treating levodopa-induced dyskinesia
|
|
US11021537B2
(en)
|
2017-05-01 |
2021-06-01 |
Agenus Inc. |
Anti-TIGIT antibodies and methods of use thereof
|
|
JOP20190219A1
(ar)
|
2017-05-09 |
2019-09-22 |
Cardix Therapeutics LLC |
تركيبات صيدلانية وطرق لعلاج أمراض القلب والأوعية الدموية
|
|
US10085999B1
(en)
|
2017-05-10 |
2018-10-02 |
Arixa Pharmaceuticals, Inc. |
Beta-lactamase inhibitors and uses thereof
|
|
US11155613B2
(en)
|
2017-06-27 |
2021-10-26 |
Neuracle Science Co., Ltd. |
Use of anti-FAM19A5 antibodies for treating fibrosis
|
|
WO2019003162A1
(en)
|
2017-06-27 |
2019-01-03 |
Neuracle Science Co., Ltd. |
USE OF ANTIBODIES DIRECTED AGAINST A SIMILARITY FAMILY OF SEQUENCE 19, MEMBER A5, FOR THE TREATMENT OF GLAUCOMA
|
|
AU2018291082B2
(en)
|
2017-06-27 |
2025-05-29 |
Neuracle Science Co., Ltd. |
Anti-FAM19A5 antibodies and uses thereof
|
|
AU2018291081B2
(en)
|
2017-06-27 |
2025-02-20 |
Neuracle Science Co., Ltd. |
Use of anti-FAM19A5 antibodies for treating cancers
|
|
EP4265257A1
(en)
|
2017-09-01 |
2023-10-25 |
East Carolina University |
Combination of a j-series prostaglandin-ethanolamide and a checkpoint inhibitor for use in treating cancer
|
|
IL309802A
(en)
|
2017-09-21 |
2024-02-01 |
Neurocrine Biosciences Inc |
High dose valbenazine formulation and related preparations, methods and kits
|
|
CN111263820B
(zh)
|
2017-10-02 |
2024-07-02 |
纽洛可科学有限公司 |
抗序列相似家族19成员a5抗体用于治疗和诊断情绪障碍的用途
|
|
CA3076920A1
(en)
|
2017-10-04 |
2019-04-11 |
The Regents Of The University Of California |
Immunomodulatory oligosaccharides
|
|
KR20250070134A
(ko)
|
2017-10-10 |
2025-05-20 |
뉴로크린 바이오사이언시즈 인코퍼레이티드 |
특정 vmat2 억제제의 투여 방법
|
|
JP2021502959A
(ja)
|
2017-10-10 |
2021-02-04 |
ニューロクライン バイオサイエンシーズ，インコーポレイテッド |
特定のｖｍａｔ２インヒビターを投与するための方法
|
|
KR20200074975A
(ko)
|
2017-10-31 |
2020-06-25 |
스태튼 바이오테크놀로지 비.브이. |
항-ApoC3 항체 및 이의 사용 방법
|
|
US20210052529A1
(en)
|
2018-01-10 |
2021-02-25 |
Cura Therapeutics, Llc |
Pharmaceutical compositions comprising dicarboxylic acids and their therapeutic applications
|
|
TWI823890B
(zh)
|
2018-01-10 |
2023-12-01 |
美商克拉治療有限責任公司 |
包含苯基磺醯胺之醫藥組合物及其治療應用
|
|
SG11202009073WA
(en)
|
2018-03-23 |
2020-10-29 |
Eidos Therapeutics Inc |
Methods of treating ttr amyloidosis using ag10
|
|
CN119607195A
(zh)
|
2018-04-24 |
2025-03-14 |
纽洛可科学有限公司 |
抗序列相似家族19成员a5的抗体在治疗神经性疼痛中的用途
|
|
US11970532B2
(en)
|
2018-05-10 |
2024-04-30 |
Neuracle Science Co., Ltd. |
Anti-family with sequence similarity 19, member A5 antibodies and method of use thereof
|
|
WO2019241555A1
(en)
|
2018-06-14 |
2019-12-19 |
Neurocrine Biosciences, Inc. |
Vmat2 inhibitor compounds, compositions, and methods relating thereto
|
|
CN108533609B
(zh)
*
|
2018-06-27 |
2020-03-10 |
贵州筑信达创科技有限公司 |
导轨及滑动件的组合结构
|
|
CN108836091B
(zh)
*
|
2018-06-27 |
2020-12-04 |
贵州筑信达创科技有限公司 |
导轨
|
|
CA3105352A1
(en)
|
2018-06-29 |
2020-01-02 |
Histogen, Inc. |
(s)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid derivatives and related compounds as caspase inhibitors for treating cardiovascular diseases
|
|
EP3824287A1
(en)
|
2018-07-20 |
2021-05-26 |
Pierre Fabre Médicament |
Receptor for vista
|
|
JOP20200336A1
(ar)
|
2018-08-15 |
2020-12-22 |
Neurocrine Biosciences Inc |
طرق إعطاء مثبطات vmat2 معينة
|
|
MA53238A
(fr)
|
2018-08-17 |
2022-04-13 |
Eidos Therapeutics Inc |
Formules d'ag10
|
|
CN112969503A
(zh)
|
2018-10-03 |
2021-06-15 |
斯塔滕生物技术有限公司 |
对人类和食蟹猕猴apoc3具有特异性的抗体和其使用方法
|
|
WO2020079595A1
(en)
|
2018-10-16 |
2020-04-23 |
Neuracle Science Co., Ltd. |
Use of anti-fam19a5 antibodies
|
|
EP3880231A1
(en)
|
2018-11-16 |
2021-09-22 |
NeoImmuneTech, Inc. |
Method of treating a tumor with a combination of il-7 protein and an immune checkpoint inhibitor
|
|
KR20200071198A
(ko)
|
2018-12-10 |
2020-06-19 |
네오이뮨텍, 인코퍼레이티드 |
Nrf2 발현 조절 기반 T 세포 항암면역치료법
|
|
JP7407461B2
(ja)
|
2018-12-19 |
2024-01-04 |
シャイ・セラピューティクス・エルエルシー |
がん、炎症性疾患、ｒａｓ病、及び線維性疾患の処置のためのｒａｓスーパーファミリーと相互作用する化合物
|
|
US12247070B2
(en)
|
2018-12-27 |
2025-03-11 |
Neuracle Science Co., Ltd. |
Use of anti-FAM19A5 antibodies for treating atherosclerosis
|
|
CA3117619A1
(en)
|
2019-01-02 |
2020-07-09 |
Neuracle Science Co., Ltd. |
Anti-family with sequence similarity 19, member a5 antibodies and method of use thereof
|
|
EP3921038A1
(en)
|
2019-02-06 |
2021-12-15 |
Dice Alpha, Inc. |
Il-17a modulators and uses thereof
|
|
CN119735688A
(zh)
|
2019-02-26 |
2025-04-01 |
茵思博纳公司 |
高-亲和力抗-mertk抗体及其用途
|
|
EP3935042B1
(en)
|
2019-03-07 |
2024-08-28 |
NOBO Medicine Inc. |
Caspase inhibitors and methods of use thereof
|
|
ES3036313T3
(en)
|
2019-05-20 |
2025-09-17 |
Nirvana Sciences Inc |
Narrow emission dyes, compositions comprising same, and methods for making and using same
|
|
JP7754724B2
(ja)
|
2019-05-20 |
2025-10-15 |
ニルバナ サイエンシーズ インク． |
発光波長の範囲が狭い発光染料、それを含む組成物及びそれを製造及び使用する方法
|
|
CA3146159A1
(en)
|
2019-07-11 |
2021-01-14 |
Cura Therapeutics, Llc |
Phenyl compounds and pharmaceutical compositions thereof, and their therapeutic applications
|
|
CA3146157A1
(en)
|
2019-07-11 |
2021-01-14 |
Cura Therapeutics, Llc |
Sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications for the treatment of neurodegenerative diseases
|
|
US10940141B1
(en)
|
2019-08-23 |
2021-03-09 |
Neurocrine Biosciences, Inc. |
Methods for the administration of certain VMAT2 inhibitors
|
|
CR20220076A
(es)
|
2019-08-30 |
2022-06-24 |
Agenus Inc |
Anticuerpos anti-cd96 y sus métodos de uso
|
|
JP7566889B2
(ja)
|
2019-09-16 |
2024-10-15 |
ダイス・アルファ・インコーポレイテッド |
Ｉｌ－１７ａモジュレーターおよびその使用
|
|
KR102337657B1
(ko)
*
|
2019-11-06 |
2021-12-09 |
한국철도기술연구원 |
철도진동저감용 조립식 블록 및 이를 이용한 블록 구조물
|
|
JP2023512456A
(ja)
|
2020-01-13 |
2023-03-27 |
ネオイミューンテック， インコーポレイテッド |
Ｉｌ－７タンパク質と二重特異性抗体の組み合わせで腫瘍を治療する方法
|
|
CN113136745B
(zh)
*
|
2020-01-17 |
2024-10-25 |
洛阳双瑞橡塑科技有限公司 |
一种轨道道床吸音减振装置
|
|
WO2021151001A1
(en)
|
2020-01-22 |
2021-07-29 |
Outpace Bio, Inc. |
Chimeric polypeptides
|
|
JP2023512657A
(ja)
|
2020-02-05 |
2023-03-28 |
ワシントン・ユニバーシティ |
Ｉｌ－７タンパク質とｃａｒ保有免疫細胞の組み合わせで固形腫瘍を治療する方法
|
|
WO2021242891A1
(en)
*
|
2020-05-27 |
2021-12-02 |
Mute Wall Systems, Inc. |
Sound dampening barrier wall
|
|
WO2021242970A1
(en)
|
2020-05-29 |
2021-12-02 |
Boulder Bioscience Llc |
Methods for improved endovascular thrombectomy using 3,3'-diindolylmethane
|
|
EP4168414A1
(en)
|
2020-06-18 |
2023-04-26 |
Shy Therapeutics LLC |
Substituted thienopyrimidines that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
|
|
JP2023532312A
(ja)
|
2020-06-30 |
2023-07-27 |
プロセッタ バイオサイエンシズ， インク． |
イソキノリン誘導体、合成の方法及びそれらの使用
|
|
WO2022061348A1
(en)
|
2020-09-16 |
2022-03-24 |
Biotheryx, Inc. |
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
|
WO2022087335A1
(en)
|
2020-10-23 |
2022-04-28 |
Biotheryx, Inc. |
Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
|
KR20230104176A
(ko)
|
2020-11-02 |
2023-07-07 |
네오이뮨텍, 인코퍼레이티드 |
코로나바이러스의 치료를 위한 인터류킨-7의 용도
|
|
CN116615236A
(zh)
|
2020-11-05 |
2023-08-18 |
新免疫技术有限公司 |
用il-7蛋白和核苷酸疫苗的组合治疗肿瘤的方法
|
|
CN112712784B
(zh)
*
|
2020-11-30 |
2024-12-31 |
南京华秦光声科技有限责任公司 |
一种低频宽带平板吸声结构
|
|
WO2022132603A1
(en)
|
2020-12-14 |
2022-06-23 |
Biotheryx, Inc. |
Pde4 degraders, pharmaceutical compositions, and therapeutic applications
|
|
WO2022164997A1
(en)
|
2021-01-27 |
2022-08-04 |
Shy Therapeutics, Llc |
Methods for the treatment of fibrotic disease
|
|
WO2022165000A1
(en)
|
2021-01-27 |
2022-08-04 |
Shy Therapeutics, Llc |
Methods for the treatment of fibrotic disease
|
|
CN117642396A
(zh)
|
2021-03-10 |
2024-03-01 |
戴斯分子Sv有限公司 |
αVβ6和αVβ1整联蛋白抑制剂及其用途
|
|
WO2022226166A1
(en)
|
2021-04-22 |
2022-10-27 |
Protego Biopharma, Inc. |
Spirocyclic imidazolidinones and imidazolidinediones for treatment of light chain amyloidosis
|
|
WO2022251533A1
(en)
|
2021-05-27 |
2022-12-01 |
Protego Biopharma, Inc. |
Heteroaryl diamide ire1/xbp1s activators
|
|
WO2022251644A1
(en)
|
2021-05-28 |
2022-12-01 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
|
EP4347826A1
(en)
|
2021-06-02 |
2024-04-10 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
|
CA3218481A1
(en)
|
2021-06-14 |
2022-12-22 |
argenx BV |
Anti-il-9 antibodies and methods of use thereof
|
|
AU2022292649A1
(en)
|
2021-06-16 |
2024-01-04 |
Biotheryx, Inc. |
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
|
WO2022266249A1
(en)
|
2021-06-16 |
2022-12-22 |
Biotheryx, Inc. |
Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
|
EP4410311A4
(en)
|
2021-09-29 |
2025-12-17 |
Nbios Inc |
FUSION PROTEIN WITH WINDED COIL CORE
|
|
WO2023069770A1
(en)
|
2021-10-22 |
2023-04-27 |
Prosetta Biosciences, Inc. |
Novel host-targeted pan-respiratory antiviral small molecule therapeutics
|
|
AU2022379973A1
(en)
|
2021-11-08 |
2024-06-27 |
Progentos Therapeutics, Inc. |
Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof
|
|
WO2023130081A1
(en)
|
2021-12-30 |
2023-07-06 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of il-7 protein and vegf antagonist
|
|
US11932665B2
(en)
|
2022-01-03 |
2024-03-19 |
Lilac Therapeutics, Inc. |
Cyclic thiol prodrugs
|
|
EP4433040A4
(en)
|
2022-01-03 |
2025-11-12 |
Lilac Therapeutics Inc |
ACYCLIC THIOL PRODRUGS
|
|
KR20230125129A
(ko)
|
2022-02-17 |
2023-08-29 |
주식회사 노벨티노빌리티 |
항체-약물 접합체
|
|
CN118922189A
(zh)
|
2022-03-02 |
2024-11-08 |
线粒体能量有限公司 |
衍生自烟酸和核糖的新型前药
|
|
WO2023192904A1
(en)
|
2022-03-30 |
2023-10-05 |
Biomarin Pharmaceutical Inc. |
Dystrophin exon skipping oligonucleotides
|
|
GB2619907A
(en)
|
2022-04-01 |
2023-12-27 |
Kanna Health Ltd |
Novel crystalline salt forms of mesembrine
|
|
US12187699B2
(en)
|
2022-04-14 |
2025-01-07 |
Bristol-Myers Squibb Company |
GSPT1 compounds and methods of use of the novel compounds
|
|
CA3257018A1
(en)
|
2022-05-05 |
2023-11-09 |
Biomarin Pharmaceutical Inc. |
METHOD FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
|
|
IL316794A
(en)
|
2022-05-10 |
2025-01-01 |
Biotheryx Inc |
CDK protease inhibitors, pharmaceuticals and therapeutic applications
|
|
CA3253951A1
(en)
|
2022-05-19 |
2023-11-23 |
Lyell Immunopharma, Inc. |
NR4A3 Targeted Polynucleotides and Their Uses
|
|
CA3267079A1
(en)
|
2022-09-09 |
2024-03-14 |
Innovo Therapeutics, Inc. |
CK1α AND DOUBLE CK1α/GSPT1 DEGRADATION COMPOUNDS
|
|
EP4593826A1
(en)
|
2022-09-30 |
2025-08-06 |
Boulder Bioscience LLC |
Compositions comprising 3,3'-diindolylmethane for treating non-hemorrhagic closed head injury
|
|
CA3268194A1
(en)
|
2022-10-21 |
2024-04-25 |
Diagonal Therapeutics Inc. |
HETEROMERIC AGONIST ANTIBODIES DIRECTED AGAINST IL-18 RECEPTOR
|
|
US20240174672A1
(en)
|
2022-10-26 |
2024-05-30 |
Protego Biopharma, Inc. |
Spirocycle Containing Pyridone Compounds
|
|
EP4608839A1
(en)
|
2022-10-26 |
2025-09-03 |
Protego Biopharma, Inc. |
Spirocycle containing bicyclic heteroaryl compounds
|
|
WO2024092043A1
(en)
|
2022-10-26 |
2024-05-02 |
Protego Biopharma, Inc. |
Spirocycle containing pyridine compounds
|
|
KR20250089492A
(ko)
|
2022-11-07 |
2025-06-18 |
네오이뮨텍, 인코퍼레이티드 |
비메틸화된 mgmt 프로모터를 갖는 종양의 치료 방법
|
|
EP4626865A1
(en)
|
2022-11-30 |
2025-10-08 |
Protego Biopharma, Inc. |
Cyclic pyrazole diamide ire1/xbp1s activators
|
|
EP4626864A1
(en)
|
2022-11-30 |
2025-10-08 |
Protego Biopharma, Inc. |
Linear heteroaryl diamide ire1/xbp1s activators
|
|
KR102870410B1
(ko)
*
|
2022-12-09 |
2025-10-16 |
한국전자기술연구원 |
방음재 및 소음 제어 시스템
|
|
WO2024194685A2
(en)
|
2023-03-17 |
2024-09-26 |
Oxitope Pharma B.V. |
Anti-phosphocholine antibodies and methods of use thereof
|
|
WO2024194686A2
(en)
|
2023-03-17 |
2024-09-26 |
Oxitope Pharma B.V. |
Anti-phosphocholine antibodies and methods of use thereof
|
|
CN121057752A
(zh)
|
2023-04-07 |
2025-12-02 |
达科纳治疗有限公司 |
铰链经修饰的双特异性抗体
|
|
WO2024211796A1
(en)
|
2023-04-07 |
2024-10-10 |
Diagonal Therapeutics Inc. |
Bispecific agonistic antibodies to activin a receptor like type 1 (alk1)
|
|
WO2024226471A2
(en)
|
2023-04-24 |
2024-10-31 |
Biomarin Pharmaceutical Inc. |
Compositions and methods for treating stxbp1 disorders
|
|
US20240368596A1
(en)
|
2023-05-05 |
2024-11-07 |
Biomarin Pharmaceutical Inc. |
Dystrophin exon skipping oligonucleotides
|
|
WO2024233642A1
(en)
|
2023-05-09 |
2024-11-14 |
Progentos Therapeutics, Inc. |
Heterocyclic compounds and uses thereof
|
|
WO2024243048A1
(en)
|
2023-05-19 |
2024-11-28 |
Diagonal Therapeutics Inc. |
Bispecific agonistic antibodies to il12 receptor
|
|
WO2025010272A1
(en)
|
2023-07-03 |
2025-01-09 |
Neoimmunetech, Inc. |
Heterodimeric fc molecules and uses thereof
|
|
TW202515919A
(zh)
|
2023-09-01 |
2025-04-16 |
比利時商艾托斯比利時公司 |
抗ｔｒｅｍ２抗體及使用方法
|
|
WO2025063888A1
(en)
|
2023-09-19 |
2025-03-27 |
Kancure Pte. Ltd. |
Survivin-targeted compounds
|
|
TW202530223A
(zh)
|
2023-09-27 |
2025-08-01 |
美商艾索司特瑞克斯公司 |
Ｍｙｓｔ抑制劑
|
|
WO2025085416A1
(en)
|
2023-10-16 |
2025-04-24 |
Bristol-Myers Squibb Company |
Gspt1 compounds and methods of use of the compounds
|
|
US20250179197A1
(en)
|
2023-10-23 |
2025-06-05 |
Diagonal Therapeutics Inc. |
Heteromeric agonistic antibodies to il-18 receptor
|
|
GB2636969A
(en)
|
2023-11-24 |
2025-07-09 |
Ontrack Therapeutics Ltd |
Novel crystalline salt forms
|
|
WO2025133707A1
(en)
|
2023-12-19 |
2025-06-26 |
Vectory Therapeutics B.V. |
Anti-tdp-43 antibodies and uses thereof
|
|
WO2025147691A1
(en)
|
2024-01-04 |
2025-07-10 |
Innovo Therapeutics, Inc. |
Compositions and methods for degrading aryl hydrocarbon receptor nuclear translocator protein
|
|
WO2025179161A1
(en)
|
2024-02-21 |
2025-08-28 |
Innovo Therapeutics, Inc. |
Protein degrading compounds
|
|
WO2025201633A1
(en)
|
2024-03-26 |
2025-10-02 |
Chen Gefei |
An agent for reducing amyloid formation
|
|
WO2025255341A1
(en)
|
2024-06-05 |
2025-12-11 |
Protego Biopharma, Inc. |
Tetrahydrofuranyl ire1/xbp1s activators
|